BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

167 related articles for article (PubMed ID: 19742317)

  • 1. AP-2alpha induces epigenetic silencing of tumor suppressive genes and microsatellite instability in head and neck squamous cell carcinoma.
    Bennett KL; Romigh T; Eng C
    PLoS One; 2009 Sep; 4(9):e6931. PubMed ID: 19742317
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Tumor suppressor activity of CCAAT/enhancer binding protein alpha is epigenetically down-regulated in head and neck squamous cell carcinoma.
    Bennett KL; Hackanson B; Smith LT; Morrison CD; Lang JC; Schuller DE; Weber F; Eng C; Plass C
    Cancer Res; 2007 May; 67(10):4657-64. PubMed ID: 17510391
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Frequent promoter hypermethylation of tumor-related genes in head and neck squamous cell carcinoma.
    Steinmann K; Sandner A; Schagdarsurengin U; Dammann RH
    Oncol Rep; 2009 Dec; 22(6):1519-26. PubMed ID: 19885608
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Epigenetic screen of human DNA repair genes identifies aberrant promoter methylation of NEIL1 in head and neck squamous cell carcinoma.
    Chaisaingmongkol J; Popanda O; Warta R; Dyckhoff G; Herpel E; Geiselhart L; Claus R; Lasitschka F; Campos B; Oakes CC; Bermejo JL; Herold-Mende C; Plass C; Schmezer P
    Oncogene; 2012 Dec; 31(49):5108-16. PubMed ID: 22286769
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Increased microsatellite instability and epigenetic inactivation of the hMLH1 gene in head and neck squamous cell carcinoma.
    Zuo C; Zhang H; Spencer HJ; Vural E; Suen JY; Schichman SA; Smoller BR; Kokoska MS; Fan CY
    Otolaryngol Head Neck Surg; 2009 Oct; 141(4):484-90. PubMed ID: 19786217
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Activator protein 2 alpha (AP2alpha) suppresses 42 kDa C/CAAT enhancer binding protein alpha (p42(C/EBPalpha)) in head and neck squamous cell carcinoma.
    Bennett KL; Romigh T; Arab K; Teresi RE; Tada Y; Eng C; Plass C
    Int J Cancer; 2009 Mar; 124(6):1285-92. PubMed ID: 19089912
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Azacitidine, as a DNMT Inhibitor Decreases hTERT Gene Expression and Telomerase Activity More Effective Compared with HDAC Inhibitor in Human Head and Neck Squamous Cell Carcinoma Cell Lines.
    Atri S; Nasoohi N; Hodjat M
    Curr Mol Pharmacol; 2021; 14(1):60-67. PubMed ID: 32394848
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Frequent 3p allele loss and epigenetic inactivation of the RASSF1A tumour suppressor gene from region 3p21.3 in head and neck squamous cell carcinoma.
    Hogg RP; Honorio S; Martinez A; Agathanggelou A; Dallol A; Fullwood P; Weichselbaum R; Kuo MJ; Maher ER; Latif F
    Eur J Cancer; 2002 Aug; 38(12):1585-92. PubMed ID: 12142046
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Resetting the histone code at CDKN2A in HNSCC by inhibition of DNA methylation.
    Coombes MM; Briggs KL; Bone JR; Clayman GL; El-Naggar AK; Dent SY
    Oncogene; 2003 Dec; 22(55):8902-11. PubMed ID: 14654786
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Target genes of microsatellite sequences in head and neck squamous cell carcinoma: mononucleotide repeats are not detected.
    Wang Y; Liu X; Li Y
    Gene; 2012 Sep; 506(1):195-201. PubMed ID: 22771919
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Fusobacterium nucleatum impairs DNA mismatch repair and stability in patients with squamous cell carcinoma of the head and neck.
    Hsueh CY; Lau HC; Huang Q; Gong H; Sun J; Cao P; Hu C; Zhang M; Tao L; Zhou L
    Cancer; 2022 Sep; 128(17):3170-3184. PubMed ID: 35789992
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Disruption of transforming growth factor-beta signaling by five frequently methylated genes leads to head and neck squamous cell carcinoma pathogenesis.
    Bennett KL; Romigh T; Eng C
    Cancer Res; 2009 Dec; 69(24):9301-5. PubMed ID: 19934318
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Reversal of epigenetic silencing of AP-2alpha results in increased zinc uptake in DU-145 and LNCaP prostate cancer cells.
    Makhov PB; Golovine KV; Kutikov A; Canter DJ; Rybko VA; Roshchin DA; Matveev VB; Uzzo RG; Kolenko VM
    Carcinogenesis; 2011 Dec; 32(12):1773-81. PubMed ID: 21940908
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Epigenetic aspects in carcinomas of the head and neck].
    Schmezer P; Plass C
    HNO; 2008 Jun; 56(6):594-602. PubMed ID: 18483718
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Genetic and epigenetic somatic alterations in head and neck squamous cell carcinomas are globally coordinated but not locally targeted.
    Poage GM; Christensen BC; Houseman EA; McClean MD; Wiencke JK; Posner MR; Clark JR; Nelson HH; Marsit CJ; Kelsey KT
    PLoS One; 2010 Mar; 5(3):e9651. PubMed ID: 20300172
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Epigenetic silencing of MAL, a putative tumor suppressor gene, can contribute to human epithelium cell carcinoma.
    Cao W; Zhang ZY; Xu Q; Sun Q; Yan M; Zhang J; Zhang P; Han ZG; Chen WT
    Mol Cancer; 2010 Nov; 9():296. PubMed ID: 21092172
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The AP-2alpha transcription factor is required for the ganglioside GM3-stimulated transcriptional regulation of a PTEN gene.
    Choi HJ; Chung TW; Kim SJ; Cho SY; Lee YS; Lee YC; Ko JH; Kim CH
    Glycobiology; 2008 May; 18(5):395-407. PubMed ID: 18316341
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prognostic significance of the methylation of Wnt pathway antagonists-CXXC4, DACT2, and the inhibitors of sonic hedgehog signaling-ZIC1, ZIC4, and HHIP in head and neck squamous cell carcinomas.
    Paluszczak J; Wiśniewska D; Kostrzewska-Poczekaj M; Kiwerska K; Grénman R; Mielcarek-Kuchta D; Jarmuż-Szymczak M
    Clin Oral Investig; 2017 Jun; 21(5):1777-1788. PubMed ID: 27553089
    [TBL] [Abstract][Full Text] [Related]  

  • 19. High frequency of microsatellite instability in young patients with head-and-neck squamous-cell carcinoma: lack of involvement of the mismatch repair genes hMLH1 AND hMSH2.
    Wang Y; Irish J; MacMillan C; Brown D; Xuan Y; Boyington C; Gullane P; Kamel-Reid S
    Int J Cancer; 2001 Aug; 93(3):353-60. PubMed ID: 11433399
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Synergistic silencing by promoter methylation and reduced AP-2α transactivation of the proapoptotic HRK gene confers apoptosis resistance and enhanced tumor growth.
    Xu M; Chen X; Chen N; Nie L; Li X; Li Q; Zeng H; Zhou Q
    Am J Pathol; 2013 Jan; 182(1):84-95. PubMed ID: 23159945
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.